Anwuligan

CAS No. 107534-93-0

Anwuligan( Macelignan )

Catalog No. M17798 CAS No. 107534-93-0

Anwuligan is a lignan isolated from nutmeg with antimicrobial and anticariogenic activity against Streptococcus mutans and other streptococcus species.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 82 In Stock
5MG 149 In Stock
10MG 249 In Stock
25MG 449 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Anwuligan
  • Note
    Research use only, not for human use.
  • Brief Description
    Anwuligan is a lignan isolated from nutmeg with antimicrobial and anticariogenic activity against Streptococcus mutans and other streptococcus species.
  • Description
    Macelignan is a lignan which can be found in the nutmeg. Macelignan acts as an NSAID with antioxidant, free radical scavenging, and neuroprotective activities.
  • In Vitro
    Macelignan (1-50 μM; 72 hours) does not reduce cell viability alone, however, UVB treatment, even at the lowest dose of 30 mJ/cm2, reduces HaCaT cell viability in a dose-dependent mannner,it reduces approximately 80% of control values at 100 μM in hacat cells.Macelignan (0.1-1 μM; 24 hours) decreases COX-2 expression in a concentration-dependent manner,and at the highest concentration of macelignan (1 μM) , COX-2 expression is inhibited by almost 50% in hacat cells. TCell Viability Assay Cell Line:Hacat cells Concentration:1 μM; 2.5 μM; 5 μM; 10 μM; 15 μM; 50 μM Incubation Time:72 hours Result:Induced cell death by UVB irradiation at 30 mJ/cm2 from 10 μM.Western Blot Analysis Cell Line:Hacat cellsConcentration:0.1 μM; 0.5 μM;1 μM Incubation Time:24 hours Result:Reduced UVB-induced COX-2 expression in cells.
  • In Vivo
    Macelignan (oral administration; 15 mg/kg; every day for three weeks) exhibits?in vivo anti-diabetic effects. The baseline (day 0) fasting blood glucose levels does not differ between groups; at the end of the experiment, the values of the Macelignan-treated group are significantly lower compared to the diabetic control group in C57BL/KsJ-db/db?mice. Animal Model:Male C57BL/KsJ-db/db?mice Dosage:15 mg/kg Administration:Oral administration; 15 mg/kg; every day for three weeksResult:Significantly reduced the blood glucose levels in mice.
  • Synonyms
    Macelignan
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    107534-93-0
  • Formula Weight
    328.41
  • Molecular Formula
    C20H24O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 30 mg/mL; 91.35 mM
  • SMILES
    c1(c(cc(cc1)C[C@@H]([C@@H](Cc1cc2OCOc2cc1)C)C)OC)O
  • Chemical Name
    Phenol, 4-((2S,3R)-4-(1,3-benzodioxol-5-yl)-2,3-dimethylbutyl)-2-methoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yang X,et al. [Selection of mobile phases for the determination of gamma-schisandrin and multi-active constituents in Schisandra chinensis and its preparations by high performance liquid chromatography].
molnova catalog
related products
  • Giredestrant

    Giredestrant potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain.?Giredestrant has anti-tumor activity.

  • GDC-0810

    GDC-0810 (ARN-810, Brilanestrant) is a non-steroidal, orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM (ER-α degradation).

  • Methyl Isoferulate

    This product is isolated and purified from the leaves of Phyllostachys heterocycla.